- Home
- ATYR vs CGO Comparison
ATYR vs CGO Comparison
Compare ATYR & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATYR | CGO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 126.4M |
| IPO Year | 2015 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ATYR | CGO |
|---|---|---|
| Price | $0.17 | $11.71 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $2.86 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 24.4K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | ★ 6.98 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $190,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $10.71 |
| 52 Week High | $1.11 | $14.20 |
Technical Indicators
Market Signals| Indicator | ATYR | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 14.10 | 31.03 |
| Support Level | N/A | $11.27 |
| Resistance Level | $0.59 | $13.35 |
| Average True Range (ATR) | 0.02 | 0.38 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 0.14 | 14.97 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.